COMMUNIQUÉS West-GlobeNewswire

Inventiva announces the nomination of Andre Turenne as Director
28/03/2024
Daix (France), Long Island City (New York, United States), March 28, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small [...]
Inventiva annonce la nomination d’Andre Turenne en tant qu’administrateur
28/03/2024
Daix (France), Long Island City (New York, États-Unis), le 28 mars 2024 – Inventiva (Euronext Paris et Nasdaq : IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement clinique de petites [...]
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
28/03/2024
The companies will leverage their combined experience in the development of conjugate vaccines for their clients Primrose Bio will supply its industry-leading carrier protein, PeliCRM197 ® , for vaccine development [...]
Sequana Medical announces 2023 Full Year Results and 2024 Outlook
28/03/2024
PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 28 March 2024, 08:00 a.m. CET alfapump ® – PMA 1 submitted to US FDA and accepted for substantive review, extensive feedback just received from FDA which is [...]
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
28/03/2024
Significant corporate and scientific progress in 2023 Innovations to End-to-End Platform technologies and IP portfolio Pipeline additions with multiple KRAS neoantigen targets Advancement of lead program MDG1015 with [...]
2023 Universal Registration Document
28/03/2024
Press Release Paris – March 28, 2024 – EUROAPI today announces that its 2023 Universal Registration Document will be filed with the French Financial Markets Authority (AMF) on April 5, 2024. Financial calendar May 22, [...]
Document d’Enregistrement Universel 2023
28/03/2024
Communiqué de presse Paris – Le 28 mars 2024 – EUROAPI annonce aujourd’hui que son Document d’Enregistrement Universel 2023 sera déposé auprès de l’Autorité des Marchés Financiers (AMF) le 5 avril 2024. Calendrier [...]
CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation
28/03/2024
High Precision System Uses Image Guidance to Target Tumor, Preserve Healthy Tissue & Reduce Risks of Complications such as ED LOS ANGELES, March 28, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, [...]
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
28/03/2024
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
28/03/2024
PRINCETON, N.J. and FRANKFURT, Germany, March 27, 2024 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy [...]
Cannabix Technologies Announces Resignation of Kulwant Malhi
28/03/2024
VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) reports that Kulwant Malhi has resigned as President and Director of [...]
Erasca Announces $45 Million Oversubscribed Private Placement Financing
28/03/2024
Funding from new and existing investors extends anticipated cash runway into H2 2026 SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS) (“Erasca”), a clinical-stage precision oncology company [...]
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
28/03/2024
— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and median OS not reached in treatment-naïve patients — — If approved, would confirm 2021 [...]
BioSyent Announces Grant of Restricted Share Units
27/03/2024
MISSISSAUGA, Ontario, March 27, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 66,020 Restricted Share Units “RSUs” to [...]
By 2035, Canada could have the most enviable healthcare system in the world if obesity is recognized as a chronic disease, predicts Obesity Canada
27/03/2024
EDMONTON, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- Nearly 30,000 deaths from noncommunicable diseases in Canada in 2019, were due to high body mass index (BMI), most related to diabetes, cardiovascular disease, and [...]
Beacon Behavioral Partners Expands to Florida with the Addition of The Neuropsychiatry & TMS Group
27/03/2024
The network of physician-driven psychiatric practices continues to expand across the Southeastern United States to enhance patient care BATON ROUGE, La., March 27, 2024 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners , a [...]
American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results
27/03/2024
- Acquisition of 3 Rhode Island Radiation Therapy Cancer Centers progressing toward closing- - International Cancer Center equipment upgrade completed in Ecuador, Opening new Puebla, Mexico Center in Q2- - Lease [...]
Gross Proceeds Close of $4M CAD Generated for NurExone From Warrants Exercise
27/03/2024
TORONTO and HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), is pleased to announce that, the Company completed a combined exercise and [...]
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
27/03/2024
CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the [...]

Pages